Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 12 studies | 26% ± 9% | |
endothelial cell | 10 studies | 25% ± 9% | |
astrocyte | 9 studies | 28% ± 12% | |
oligodendrocyte precursor cell | 8 studies | 32% ± 14% | |
GABAergic neuron | 7 studies | 37% ± 17% | |
epithelial cell | 6 studies | 29% ± 8% | |
neuron | 5 studies | 23% ± 10% | |
interneuron | 5 studies | 37% ± 23% | |
adipocyte | 5 studies | 22% ± 4% | |
glutamatergic neuron | 5 studies | 45% ± 22% | |
fibroblast | 5 studies | 27% ± 7% | |
granule cell | 4 studies | 20% ± 3% | |
goblet cell | 4 studies | 28% ± 14% | |
endothelial cell of lymphatic vessel | 4 studies | 19% ± 3% | |
GABAergic interneuron | 3 studies | 19% ± 4% | |
glial cell | 3 studies | 20% ± 1% | |
ciliated cell | 3 studies | 18% ± 1% | |
abnormal cell | 3 studies | 29% ± 11% | |
hepatocyte | 3 studies | 39% ± 17% | |
Schwann cell | 3 studies | 34% ± 22% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 9 studies | 34% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 5017.31 | 245 / 245 | 100% | 93.28 | 502 / 502 |
breast | 100% | 5335.93 | 459 / 459 | 100% | 151.84 | 1115 / 1118 |
brain | 100% | 3944.38 | 2637 / 2642 | 100% | 84.01 | 703 / 705 |
esophagus | 100% | 5044.00 | 1445 / 1445 | 99% | 53.02 | 182 / 183 |
pancreas | 100% | 2719.91 | 328 / 328 | 98% | 53.46 | 175 / 178 |
liver | 100% | 3691.85 | 226 / 226 | 98% | 69.81 | 397 / 406 |
intestine | 100% | 5949.51 | 966 / 966 | 98% | 43.51 | 515 / 527 |
uterus | 100% | 4189.75 | 170 / 170 | 97% | 56.48 | 446 / 459 |
stomach | 100% | 4016.39 | 359 / 359 | 97% | 41.89 | 276 / 286 |
kidney | 100% | 2767.69 | 89 / 89 | 95% | 62.82 | 856 / 901 |
thymus | 100% | 3589.26 | 653 / 653 | 95% | 36.76 | 574 / 605 |
adrenal gland | 100% | 12690.71 | 258 / 258 | 95% | 44.21 | 218 / 230 |
bladder | 100% | 4465.38 | 21 / 21 | 93% | 36.22 | 471 / 504 |
lung | 99% | 3371.49 | 574 / 578 | 94% | 38.66 | 1081 / 1155 |
ovary | 100% | 3550.02 | 180 / 180 | 93% | 27.42 | 399 / 430 |
skin | 100% | 3639.84 | 1807 / 1809 | 92% | 55.94 | 434 / 472 |
adipose | 100% | 4452.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3413.42 | 1335 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 48.47 | 45 / 45 |
spleen | 100% | 1854.16 | 240 / 241 | 0% | 0 | 0 / 0 |
muscle | 96% | 1382.18 | 773 / 803 | 0% | 0 | 0 / 0 |
heart | 93% | 1535.31 | 799 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 60% | 16.44 | 48 / 80 |
peripheral blood | 18% | 236.69 | 165 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 2.49 | 4 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051260 | Biological process | protein homooligomerization |
GO_0005886 | Cellular component | plasma membrane |
Gene name | KCTD3 |
Protein name | Alternative protein KCTD3 Potassium channel tetramerization domain containing 3 BTB/POZ domain-containing protein KCTD3 (Renal carcinoma antigen NY-REN-45) |
Synonyms | |
Description | FUNCTION: Accessory subunit of potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 (HCN3) up-regulating its cell-surface expression and current density without affecting its voltage dependence and kinetics. . |
Accessions | H0Y5P8 L0R4Z3 H0Y566 ENST00000448333.1 ENST00000259154.9 [Q9Y597-1] ENST00000452413.1 Q9Y597 |